ABS — Arctic Bioscience AS Balance Sheet
0.000.00%
- NOK78.90m
- NOK86.28m
- NOK43.48m
- 15
- 47
- 38
- 21
Annual balance sheet for Arctic Bioscience AS, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | NAS | NAS | NAS | NAS | NAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14.2 | 231 | 149 | 90.8 | 14.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11 | 7.7 | 13.5 | 9.57 | 14.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 52.6 | 267 | 198 | 133 | 57.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6.36 | 16 | 22.3 | 26.4 | 24.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 93.2 | 341 | 328 | 300 | 280 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.7 | 20.9 | 40.4 | 39.6 | 67.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 29.3 | 20.9 | 40.4 | 41.7 | 69 |
Common Stock | |||||
Additional Paid In Capital | |||||
Other Equity | |||||
Total Equity | 63.9 | 321 | 287 | 259 | 211 |
Total Liabilities & Shareholders' Equity | 93.2 | 341 | 328 | 300 | 280 |
Total Common Shares Outstanding |